Gujarat Kidney Shares Debut with Over 5% Premium on D-Street
Shares of Gujarat Kidney & Super Speciality Ltd. made a strong debut on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), listing at a premium of 5.92% and 5.26% respectively. The stock opened at Rs 120.75 apiece on the BSE and Rs 120 per share on the NSE, compared to the issue price of Rs 114 per share.
IPO Subscription and Details
The Gujarat Kidney public offer was subscribed 3.71 times, with the issue consisting entirely of a fresh issue of 2.2 crore equity shares. The price band for the issue was set at Rs 108 to Rs 114 per share. Nirbhay Capital Services Pvt. Ltd. acted as the book-running lead manager for the IPO, while MUFG Intime India Ltd. was the issue registrar.
The company plans to utilize the IPO funds for the acquisition of Ahmedabad-based Parekhs Hospital and capital expenditure toward setting up a new hospital in Vadodara. A portion of the IPO proceeds will also be used for repayment of debts, funding of inorganic growth, and acquisition of additional shares in its subsidiary, Harmony Medicare.
Company Overview
Gujarat Kidney and Super Speciality Ltd., incorporated in 2019, provides multi-speciality healthcare services across multiple cities in Gujarat. It operates seven multi-speciality hospitals with a total bed capacity of 490 beds. The company’s focus on providing quality healthcare services has helped it establish a strong presence in the region.
For investors looking to tap into the growing healthcare sector in India, Gujarat Kidney’s IPO debut is a significant development. The healthcare sector in India has been witnessing significant growth, driven by increasing demand for quality healthcare services and government initiatives to improve healthcare infrastructure.
Investment Opportunities in the Healthcare Sector
The listing of Gujarat Kidney shares is expected to attract investors looking to invest in the Indian healthcare sector. The sector has seen significant investments in recent years, with several companies listing on the stock exchanges. The growth prospects of the sector, coupled with the increasing demand for healthcare services, make it an attractive investment opportunity.
Investors can consider investing in pharmaceutical stocks, healthcare services stocks, and medical devices stocks to tap into the growth potential of the sector. However, it is essential to conduct thorough research and analysis before making any investment decisions.
Conclusion
The listing of Gujarat Kidney shares marks a significant development in the Indian stock market, particularly in the healthcare sector. The company’s strong debut is expected to attract investors looking to invest in the sector. With the growing demand for quality healthcare services and government initiatives to improve healthcare infrastructure, the Indian stock market is likely to witness significant growth in the healthcare sector.